← Mechanisms of action
EEF2
SINGLE PROTEINHomo sapiens
Preferred name: Elongation factor 2 ChEMBL ↗
Linked proteins
Drugs acting on this target (11)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| lmb-100 | Disrupting agent | experimental | mAb | Elongation factor 2 disrupting agent |
| anti-tac(fv)-pe38 | Inhibitor | experimental | mAb | Elongation factor 2 inhibitor |
| b3(fv)-pe38 | Inhibitor | experimental | mAb | Elongation factor 2 inhibitor |
| cintredekin besudotox | Inhibitor | experimental | Recombinant protein | Elongation factor 2 inhibitor |
| denileukin diftitox (ontak) | Inhibitor | approved | Recombinant protein | EEF2 inhibitor |
| lmb-1 | Inhibitor | experimental | mAb | Elongation factor 2 inhibitor |
| lmb-9 | Inhibitor | experimental | mAb | Elongation factor 2 inhibitor |
| moxetumomab pasudotox (Lumoxiti) | Inhibitor | approved | mAb | Elongation factor 2 inhibitor |
| proxinium | Inhibitor | experimental | mAb | Elongation factor 2 inhibitor |
| resimmune | Inhibitor | experimental | mAb | Elongation factor 2 inhibitor |
| tagraxofusp-erzs (elzonris) | Inhibitor | approved | Recombinant protein | Elongation factor 2 inhibitor |